OTC Healthcare in Serbia and Montenegro
Euromonitor International's OTC Healthcare in Serbia and Montenegro market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 16 | Publication date: Mar 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Dynamic growth
In 2005 OTC healthcare current value sales showed strong year-on-year growth to reach YUD4 billion. The market registered an impressive current value CAGR over the 2000-2005 review period as a whole. Although high constant value growth rates were also recorded during the review period, it is expected that the rate of growth in constant value sales will slow considerably over the forecast period.
Poorly regulated pharmaceuticals industry negatively affects sales of OTC healthcare
As a result of a health system where privately-owned pharmacies offer most medicines and medical products free with a prescription, most consumers generally opt to buy non-OTC medicines, as these are also perceived to be stronger and therefore more effective. As a result, sales of OTC products were not particularly high over the review period. However, when the pharmaceuticals industry becomes more regulated, there could be potential for higher sales of OTC healthcare products. Although a dual health system (state-run and private) is in place, the two branches are not compatible or comparable.
Increased competition in OTC healthcare
As the new law for Medicines and Medical Devices was approved in parliament in 2004, basic rules were put in place to develop the OTC healthcare market in Serbia and Montenegro, which was until then undeveloped and neglected. Domestic manufacturer Hemofarm undertook a specific OTC programme called “Moja Apoteka” (My Pharmacy) and like other domestic companies, worked continuously with the regulators and promoted OTC healthcare products through extensive advertising campaigns.
Direct sales remains strong
CaliVita, operating in the direct sales channel in Serbia and Montenegro, maintained its share of the OTC healthcare market, by building up a vast network of sellers and users and offering a wide selection of vitamins and dietary supplements in particular. Other direct sales companies are also emerging in vitamins and dietary supplements, which is becoming a highly competitive sector and one that is particularly attractive to direct sales companies.
Consumer health education on the rise
Numerous advertising campaigns were undertaken which aimed to raise awareness of OTC healthcare products, as well as the importance of taking care of the health. Popular weekly or monthly magazines are currently filled with articles about healthy living and advertisements of OTC healthcare products. This has in turn resulted in increasing interest in self-medication in pharmaceutical products as a whole.
Table of contents
OTC HEALTHCARE IN SERBIA AND MONTENEGRO : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Consumer Expenditure on Health Goods and Medical Services
Life Expectancy
Table 1 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 2 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 3 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Competitive Environment
Table 4 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 5 OTC Healthcare Brand Shares by Retail Value 2002-2005
Leading Company Profile: Hemofarm Koncern ad
Summary 1 Hemofarm Koncern ad: Operational Indicators 2004
Leading Company Profile: Galenika ad
Summary 2 Galenika ad: Operational Indicators 2004
New Product Developments
Summary 3 OTC Healthchare: New Product Launches 2004-2005
Retail Distribution
Table 6 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 7 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Forecast Market Performance
Table 8 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
MARKET SECTORS
Analgesics
Summary 4 Analgesics: New Product Launches 2005
Cough, Cold and Allergy (Hay Fever) Remedies
Summary 5 Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004
Digestive Remedies
Medicated Skin Care
Summary 6 Medicated Skin Care: New Product Launches 2004
Vitamins and Dietary Supplements
Summary 7 Vitamins and Dietary Supplements: New Product Launches 2004-2006
NRT Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouthcare
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
DEFINITIONS